Cargando…

Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives

BACKGROUND: Although it is well documented that adolescents and young adults (AYAs) with cancer have low participation in cancer clinical trials (CCTs), the underlying reasons are not well understood. We used the National Cancer Institute Community Oncology Research Program (NCORP) network to identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Siembida, Elizabeth J, Loomans-Kropp, Holli A, Tami-Maury, Irene, Freyer, David R, Sung, Lillian, Crosswell, Howland E, Pollock, Brad H, Roth, Michael E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178801/
https://www.ncbi.nlm.nih.gov/pubmed/34104866
http://dx.doi.org/10.1093/jncics/pkab027
_version_ 1783703650021933056
author Siembida, Elizabeth J
Loomans-Kropp, Holli A
Tami-Maury, Irene
Freyer, David R
Sung, Lillian
Crosswell, Howland E
Pollock, Brad H
Roth, Michael E
author_facet Siembida, Elizabeth J
Loomans-Kropp, Holli A
Tami-Maury, Irene
Freyer, David R
Sung, Lillian
Crosswell, Howland E
Pollock, Brad H
Roth, Michael E
author_sort Siembida, Elizabeth J
collection PubMed
description BACKGROUND: Although it is well documented that adolescents and young adults (AYAs) with cancer have low participation in cancer clinical trials (CCTs), the underlying reasons are not well understood. We used the National Cancer Institute Community Oncology Research Program (NCORP) network to identify barriers and facilitators to AYA CCT enrollment, and strategies to improve enrollment at community-based and minority and/or underserved sites. METHODS: We performed one-on-one semistructured qualitative interviews with stakeholders (NCORP site principle investigators, NCORP administrators, physicians involved in enrollment, lead clinical research associates or clinical research nurses, nurse navigators, regulatory research associates, patient advocates) in the AYA CCT enrollment process. NCORP sites that included high and low AYA–enrolling affiliate sites and were diverse in geography and department representation (eg, pediatrics, medical oncology) were invited to participate. All interviews were recorded and transcribed. Themes related to barriers and facilitators and strategies to improve enrollment were identified. RESULTS: We conducted 43 interviews across 10 NCORP sites. Eleven barriers and 13 facilitators to AYA enrollment were identified. Main barriers included perceived limited trial availability and eligibility, physician gatekeeping, lack of provider and research staff time, and financial constraints. Main facilitators and strategies to improve AYA enrollment included having a patient screening process, physician endorsement of trials, an “AYA champion” on site, and strong communication between medical and pediatric oncology. CONCLUSIONS: Stakeholders identified several opportunities to address barriers contributing to low AYA CCT enrollment at community-based and minority and/or underserved sites. Results of this study will inform development and implementation of targeted interventions to increase AYA CCT enrollment.
format Online
Article
Text
id pubmed-8178801
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-81788012021-06-07 Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives Siembida, Elizabeth J Loomans-Kropp, Holli A Tami-Maury, Irene Freyer, David R Sung, Lillian Crosswell, Howland E Pollock, Brad H Roth, Michael E JNCI Cancer Spectr Article BACKGROUND: Although it is well documented that adolescents and young adults (AYAs) with cancer have low participation in cancer clinical trials (CCTs), the underlying reasons are not well understood. We used the National Cancer Institute Community Oncology Research Program (NCORP) network to identify barriers and facilitators to AYA CCT enrollment, and strategies to improve enrollment at community-based and minority and/or underserved sites. METHODS: We performed one-on-one semistructured qualitative interviews with stakeholders (NCORP site principle investigators, NCORP administrators, physicians involved in enrollment, lead clinical research associates or clinical research nurses, nurse navigators, regulatory research associates, patient advocates) in the AYA CCT enrollment process. NCORP sites that included high and low AYA–enrolling affiliate sites and were diverse in geography and department representation (eg, pediatrics, medical oncology) were invited to participate. All interviews were recorded and transcribed. Themes related to barriers and facilitators and strategies to improve enrollment were identified. RESULTS: We conducted 43 interviews across 10 NCORP sites. Eleven barriers and 13 facilitators to AYA enrollment were identified. Main barriers included perceived limited trial availability and eligibility, physician gatekeeping, lack of provider and research staff time, and financial constraints. Main facilitators and strategies to improve AYA enrollment included having a patient screening process, physician endorsement of trials, an “AYA champion” on site, and strong communication between medical and pediatric oncology. CONCLUSIONS: Stakeholders identified several opportunities to address barriers contributing to low AYA CCT enrollment at community-based and minority and/or underserved sites. Results of this study will inform development and implementation of targeted interventions to increase AYA CCT enrollment. Oxford University Press 2021-03-22 /pmc/articles/PMC8178801/ /pubmed/34104866 http://dx.doi.org/10.1093/jncics/pkab027 Text en © The Author(s) 2021. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Article
Siembida, Elizabeth J
Loomans-Kropp, Holli A
Tami-Maury, Irene
Freyer, David R
Sung, Lillian
Crosswell, Howland E
Pollock, Brad H
Roth, Michael E
Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives
title Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives
title_full Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives
title_fullStr Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives
title_full_unstemmed Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives
title_short Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives
title_sort barriers and facilitators to adolescent and young adult cancer trial enrollment: ncorp site perspectives
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178801/
https://www.ncbi.nlm.nih.gov/pubmed/34104866
http://dx.doi.org/10.1093/jncics/pkab027
work_keys_str_mv AT siembidaelizabethj barriersandfacilitatorstoadolescentandyoungadultcancertrialenrollmentncorpsiteperspectives
AT loomanskropphollia barriersandfacilitatorstoadolescentandyoungadultcancertrialenrollmentncorpsiteperspectives
AT tamimauryirene barriersandfacilitatorstoadolescentandyoungadultcancertrialenrollmentncorpsiteperspectives
AT freyerdavidr barriersandfacilitatorstoadolescentandyoungadultcancertrialenrollmentncorpsiteperspectives
AT sunglillian barriersandfacilitatorstoadolescentandyoungadultcancertrialenrollmentncorpsiteperspectives
AT crosswellhowlande barriersandfacilitatorstoadolescentandyoungadultcancertrialenrollmentncorpsiteperspectives
AT pollockbradh barriersandfacilitatorstoadolescentandyoungadultcancertrialenrollmentncorpsiteperspectives
AT rothmichaele barriersandfacilitatorstoadolescentandyoungadultcancertrialenrollmentncorpsiteperspectives